Showing results (301-310 of 528) with videos related to

Sort By:
Pageof 53
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Plos Pathogens|July 11, 2015
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion GlycoproteinMorgan S A Gilman, Syed M Moin, Vicente Mas, et al.
Immunity|September 30, 2019
Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza VirusMaya Sangesland, Larance Ronsard, Samuel W Kazer, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Antigen spacing on protein nanoparticles influences antibody responses to vaccinationDaniel Ellis, Annie Dosey, Seyhan Boyoglu-Barnum, et al.
Plos One|November 16, 2016
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)Michelle C Crank, Eleanor M P Wilson, Laura Novik, et al.
Plos One|October 27, 2017
Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virusMallika Sastry, Baoshan Zhang, Man Chen, et al.
Science Immunology|March 22, 2024
C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoireIvan Kosik, Jefferson Da Silva Santos, Mathew Angel, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2022
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza virusesMeagan McMahon, George O'Dell, Jessica Tan, et al.
The Journal of Infectious Diseases|September 17, 2014
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trialUzma N Sarwar, Pamela Costner, Mary E Enama, et al.
Plos Biology|February 22, 2019
Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogenFabian Sesterhenn, Marie Galloux, Sabrina S Vollers, et al.
Pageof 53